Compare REPL & HFWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | REPL | HFWA |
|---|---|---|
| Founded | 2015 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 454.6M | 1.1B |
| IPO Year | 2018 | 1997 |
| Metric | REPL | HFWA |
|---|---|---|
| Price | $15.57 | $28.89 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 4 |
| Target Price | $5.67 | ★ $30.50 |
| AVG Volume (30 Days) | ★ 7.4M | 341.6K |
| Earning Date | 05-21-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.53% |
| EPS Growth | N/A | ★ 58.06 |
| EPS | N/A | ★ 0.90 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $45.85 |
| Revenue Next Year | N/A | $7.83 |
| P/E Ratio | ★ N/A | $32.27 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.50 | $21.32 |
| 52 Week High | $15.71 | $31.25 |
| Indicator | REPL | HFWA |
|---|---|---|
| Relative Strength Index (RSI) | 60.32 | 43.89 |
| Support Level | $9.01 | $28.94 |
| Resistance Level | $15.71 | $29.29 |
| Average True Range (ATR) | 1.17 | 0.45 |
| MACD | 0.02 | -0.10 |
| Stochastic Oscillator | 77.95 | 28.81 |
Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic immunotherapy product candidates are designed and intended to maximally activate the immune system against cancer. Oncolytic immunotherapy is an emerging drug class. The proprietary RPx platform is based on a novel, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added that are intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. It operates in single segment of developing oncolytic immunotherapies for the treatment of cancer.
Heritage Financial Corp is a bank holding company. The company, through its subsidiary, provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as non-interest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.